Some owners of Chinese condom and sex-toy brand Jissbon are considering a minority stake sale, people familiar with the matter said.
Jissbon backers including Hillhouse and Humanwell Healthcare Group Co. are exploring the sale of about 20% to 30% of the Chinese business, according to the people, who asked not to be identified because the information isn’t public. They’ve been holding talks with potential buyers including private equity firms CVC Capital Partners and Advent, the people said.
Deliberations are ongoing and may not result in a transaction, the people said.
Jissbon was separated from Lifestyles Healthcare in 2022 after the ...
